Cancer News, Treatment and Research

Good Wednesday Morning, Its July 27th, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. for its second quarter ended June 30, 2011, Questcor Pharmaceuticals Incorporated – symbol QCOR – posted record net sales of $46.0 million, a 62% increased year-over-year Vringo Incorporated – symbol VRNG – reported $2.5 Million Investment Led by Prominent Venture Capital Firms Benchmark Capital and DAG Ventures. The compoany Also Announced Signing of Letter of intent to Acquire and Merge Operations with Mobile Messaging Firm Zlango Limited. and finally, Marshall Edwards Incorporated – symbol MSHL – announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells. The company believes these encouraging data provide sufficient proof of concept to warrant further study in ovarian cancer patients. Ovarian cancer is the fifth most common cancer among women, and it causes more deaths than any other type of female reproductive cancer. Thanks for joining me and have a great one! For CRWE Newswire, Stocks In Action, I’m Sara Bryant ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at www.crwenewswire.com …